Diabetes Act

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: $390,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to electronic prescribing, including clinical data element template for Durable Medical Equipment. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to competitive bidding for diabetes devices: S.4037, Diabetes Act.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)

Client expense: $400,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to combatting fraud, waste and abuse in the Medicare program - specifically related to the way continuous glucose monitors are billed in Medicare and potential solutions to vet durable medical equipment vendors at CMS. Issues related to wearable health care devices.

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; Policy related to the use of Continuous Glucose Monitors and access to insulin; Insulin Act (S. 4189 / H.R. 3014); Diabetes Act (S. 4037); Drug pricing/PBM Reform.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: $360,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Lobbied in favor of HR 2005 - Medicare reimbursement expansion Lobbied in favor of S 247 & HR 1703 - access to titanium and carbon fiber wheelchairs Lobbied in favor of S 4037 - the Diabetes Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to diabetes management and durable medical equipment reimbursement channels. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the disease of diabetes, diabetes therapies, automated insulin delivery devices, and management of the disease of diabetes. Issues related to medical devices and medical device technologies. Issues related to Pharmacy Benefit Manager (PBM) reform proposals, PBM transparency and potential PBM proposals related to talks of future budget reconciliation package. Issues related to the reintroduction of the DIABETES Act (S.4037) in the 119th Congress. Issues related to artificial intelligence (AI) and predictive algorithms in medical devices and medical device technology. Issues related to tariffs and trade and the Sec. 232 Tariff investigation related to Medical Devices. Issues related to Local Coverage Determination revisions specifically in pathways for Continuous Glucose Monitors (CGM). Issues related to National Coverage Determination revisions specifically in reference to durable infusion insulin pumps. Issues related to Prior Authorizations in Medicare Advantage plans. Issues related to support of Improving Seniors' Timely Access to Care Act. Issues related to CMS finalized rule, DMEPOS Home Health Rule. Issues related to expansion of Competitive Bidding Program and implementation of CMS finalized rule relating to DMEPOS Home Health Rule. Issues related to wearable health care devices.

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: $480,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S.1406 - SOAR Act of 2025; Issues related to S.4037 Diabetes Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE